Articles

Results 1 to 5 of 5
Most popular |Most recent


COVID-19 Accelerates Digital Transformation at the European Patent Office

European Union - April 23 2020 Oral proceedings before examining divisions ("EDs") of the European Patent Office ("EPO") will now be held by videoconference pursuant to the April 1…

Dr. Olga Bezzubova, Dr. Sven Rihm.

New Decade, New Rules: Rules of Procedure of the Boards of Appeal 2020 Entered into Force

European Union - April 8 2020 In Short The Situation: The new Rules of Procedure of the Boards of Appeal of the European Patent Office ("EPO") entered into force on January 1, 2020…

Dr. Olga Bezzubova.

Extension of Protection for Up to One Year Possible? New Referral on Double Patenting

European Union - March 25 2019 The BoA has been divergent regarding whether in an internal priority situation, the applicant would have a legitimate interest in a second patent…

Andreas Holzwarth-Rochford, Dr. Olga Bezzubova.

Disclaimers Double Standard Acknowledged by European Patent Office

European Union - March 7 2018 A recent decision by the Enlarged Board of Appeal of the European Patent Office confirmed that a 2011 ruling dealing with disclosed disclaimers does…

Dr. Olga Bezzubova.

Methods of treatment in Europe: patent claims covering second or further medical uses and dosage regimens

European Union - November 18 2010 The decision G 2/08 of February 19, 2010 (published October 28, 2010) of the Enlarged Board of Appeal (EBA) of the European Patent Office confirms that a substance or composition known as a medicament for treating a certain illness can be patented for use in a different treatment by therapy of the same disease.

Martin Weber.